{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:49:32Z","timestamp":1760060972623,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jsat.2021.108687","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:26:51Z","timestamp":1638923211000},"page":"108687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Assessing the impact of social distancing measures implemented during COVID-19 pandemic on medications for opioid use disorder in West Virginia"],"prefix":"10.1016","volume":"136","author":[{"given":"Treah","family":"Haggerty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Khodaverdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Dekeseredy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Hendricks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Peklinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cara L.","family":"Sedney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jsat.2021.108687_bb0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10550887.2012.694598","article-title":"Maintenance medication for opiate addiction: The foundation of recovery","volume":"31","author":"Bart","year":"2012","journal-title":"Journal of Addictive Diseases"},{"issue":"1","key":"10.1016\/j.jsat.2021.108687_bb0010","first-page":"348","article-title":"Interrupted time series regression for the evaluation of public health interventions: A tutorial","volume":"46","author":"Bernal","year":"2017","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1016\/j.jsat.2021.108687_bb0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/A:1010024016308","article-title":"The value of interrupted time-series experiments for community intervention research","volume":"1","author":"Biglan","year":"2000","journal-title":"Prevention Science"},{"year":"2015","series-title":"Time series analysis: Forecasting and control","author":"Box","key":"10.1016\/j.jsat.2021.108687_bb0020"},{"issue":"23","key":"10.1016\/j.jsat.2021.108687_bb0025","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2020.22154","article-title":"Changes in outpatient buprenorphine dispensing during the COVID-19 pandemic","volume":"324","author":"Cance","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2021.108687_bb0030","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s11606-020-06436-3","article-title":"COVID-19 adaptations in the care of patients with opioid use disorder: A survey of California primary care clinics","volume":"36","author":"Caton","year":"2021","journal-title":"Journal of General Internal Medicine"},{"year":"2021","series-title":"1135 waivers","key":"10.1016\/j.jsat.2021.108687_bb0035"},{"issue":"2","key":"10.1016\/j.jsat.2021.108687_bb0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/00401706.1988.10488367","article-title":"Estimation of time series parameters in the presence of outliers","volume":"20","author":"Chang","year":"2012","journal-title":"Technometrics"},{"key":"10.1016\/j.jsat.2021.108687_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.pmedr.2019.100871","article-title":"School and preparedness officials\u2019 perspectives on social distancing practices to reduce influenza transmission during a pandemic: Considerations to guide future work","volume":"14","author":"Faherty","year":"2019","journal-title":"Preventive Medicine Reports"},{"issue":"2","key":"10.1016\/j.jsat.2021.108687_bb0050","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1176\/appi.ps.201300235","article-title":"Medication-assisted treatment with methadone: Assessing the evidence","volume":"65","author":"Fullerton","year":"2014","journal-title":"Psychiatric Services"},{"issue":"5","key":"10.1016\/j.jsat.2021.108687_bb0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M17-0865","article-title":"Prescription opioid use, misuse, and use disorders in US adults: 2015 National Survey on drug use and health","volume":"167","author":"Han","year":"2017","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2021.108687_bb0060","doi-asserted-by":"crossref","DOI":"10.1111\/jrh.12570","article-title":"An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the COVID-19 pandemic","author":"Hughes","year":"2021","journal-title":"The Journal of Rural Health"},{"key":"10.1016\/j.jsat.2021.108687_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108486","article-title":"Comparing actual and forecasted numbers of unique patients dispensed select medications for opioid use disorder, opioid overdose reversal, and mental health, during the COVID-19 pandemic, United States, January 2019 to May 2020","volume":"219","author":"Jones","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.jsat.2021.108687_bb0070","doi-asserted-by":"crossref","DOI":"10.2196\/29298","article-title":"Increases in naloxone administrations by emergency medical services providers during the COVID-19 pandemic: Retrospective time series study","volume":"7","author":"Khoury","year":"2021","journal-title":"JMIR Public Health and Surveillance"},{"issue":"12","key":"10.1016\/j.jsat.2021.108687_bb0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/adaw.32664","article-title":"DEA, SAMHSA relax OTP\/OBOT regulations due to COVID-19tle","volume":"32","author":"Knopf","year":"2020","journal-title":"Alcoholism & Drug Abuse Weekly"},{"key":"10.1016\/j.jsat.2021.108687_bb0080","article-title":"\u201cHow will I get my next week\u2019s script?\u201d Reactions of reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic","volume":"103140","author":"Krawczyk","year":"2021","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.jsat.2021.108687_bb0085","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/heapol\/czr004","article-title":"How to do (or not to do)\u2026 assessing the impact of a policy change with routine longitudinal data","volume":"27","author":"Lagarde","year":"2012","journal-title":"Health Policy and Planning"},{"key":"10.1016\/j.jsat.2021.108687_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116712","article-title":"Long-term treatment retention in West Virginia\u2019s comprehensive opioid addiction treatment (COAT) program","volume":"411","author":"Lander","year":"2020","journal-title":"Journal of the Neurological Sciences"},{"year":"2019","series-title":"Interrupted time series analysis","author":"McDowall","key":"10.1016\/j.jsat.2021.108687_bb0095"},{"key":"10.1016\/j.jsat.2021.108687_bb0100","first-page":"1","article-title":"COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management","author":"Mehtani","year":"2021","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2021.108687_bb0105","series-title":"A retrospective cohort study comparing in-person and telemedicine-based opioid agonist treatment in Ontario, Canada, using administrative health data","first-page":"1","author":"Morin","year":"2021"},{"year":"2020","series-title":"West Virginia: Opioid-involved deaths and related harms","key":"10.1016\/j.jsat.2021.108687_bb0110"},{"issue":"24(S1)","key":"10.1016\/j.jsat.2021.108687_bb0115","article-title":"The opioid epidemic within the COVID-19 pandemic: Drug testing in 2020","volume":"1","author":"Niles","year":"2021","journal-title":"Population Health Management"},{"key":"10.1016\/j.jsat.2021.108687_bb0120","unstructured":"Office of the Governor Jim Justice, n.d. Office of the Governor Jim Justice. (n.d.). Covid-19 actions & executive orders. Retrieved April 4, 2021, from https:\/\/governor.wv.gov\/Pages\/WV-COVID-19-actions-and-executive-orders.aspx."},{"issue":"6","key":"10.1016\/j.jsat.2021.108687_bb0125","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.acap.2013.08.002","article-title":"Use of interrupted time series analysis in evaluating health care quality improvements","volume":"13","author":"Penfold","year":"2013","journal-title":"Academic Pediatrics"},{"issue":"1","key":"10.1016\/j.jsat.2021.108687_bb0130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/1357633X16674087","article-title":"Evaluating barriers to adopting telemedicine worldwide: A systematic review","volume":"24","author":"Scott Kruse","year":"2018","journal-title":"Journal of Telemedicine and Telecare"},{"issue":"1","key":"10.1016\/j.jsat.2021.108687_bb0135","article-title":"Assessing the impact of a restrictive opioid prescribing law in West Virginia","volume":"16","author":"Sedney","year":"2021","journal-title":"Substance Abuse: Treatment, Prevention, and Policy"},{"year":"2020","series-title":"H.R. 6074","key":"10.1016\/j.jsat.2021.108687_bb0140"},{"issue":"2","key":"10.1016\/j.jsat.2021.108687_bb0145","article-title":"Perceived ability to treat opioid use disorder in West Virginia","volume":"3","author":"Sheppard","year":"2021","journal-title":"Journal of Appalachian Health"},{"issue":"11","key":"10.1016\/j.jsat.2021.108687_bb0150","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1517\/14656560903037168","article-title":"Opioid dependence treatment: Options in pharmacotherapy","volume":"10","author":"Stotts","year":"2009","journal-title":"Xpert Opinion on Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.jsat.2021.108687_bb0155","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/YCO.0000000000000722","article-title":"Converging public health crises: Substance use during the coronavirus disease 2019 pandemic","volume":"34","author":"Striley","year":"2021","journal-title":"Current Opinion in Psychiatry"},{"key":"10.1016\/j.jsat.2021.108687_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108263","article-title":"Leveraging COVID-19 to sustain regulatory flexibility in the treatment of opioid use disorder","volume":"123","author":"Stringer","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108687_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2019.08.003","article-title":"Expanding treatment for opioid use disorder in publicly funded primary care clinics: Exploratory evaluation of the NYC health+ hospitals buprenorphine ECHO program","volume":"106","author":"Tofighi","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"year":"2020","series-title":"Anniversary of Americans with disabilities act: July 26, 2020","key":"10.1016\/j.jsat.2021.108687_bb0170"},{"key":"10.1016\/j.jsat.2021.108687_bb0175","unstructured":"United States Census Bureau, n.d.United States Census Bureau. (n.d.). Quick facts West Virginia. Retrieved September 23, 2021, from https:\/\/www.census.gov\/quickfacts\/fact\/table\/WV\/LFE041219#LFE041219."},{"issue":"11","key":"10.1016\/j.jsat.2021.108687_bb0180","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1176\/appi.ps.202000250","article-title":"Suddenly becoming a \u201cvirtual doctor\u201d: Experiences of psychiatrists transitioning to telemedicine during the COVID-19 pandemic","volume":"71","author":"Uscher-Pines","year":"2020","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.jsat.2021.108687_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108272","article-title":"Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic","volume":"124","author":"Wang","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2021.108687_bb0190","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jsat.2019.05.005","article-title":"West Virginia\u2019s model of buprenorphine expansion: Preliminary results","volume":"108","author":"Winstanley","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"year":"2020","series-title":"WHO director-general\u2019s opening remarks at the media briefing on COVID-19 - 11 March 2020","key":"10.1016\/j.jsat.2021.108687_bb0195"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074054722100413X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074054722100413X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:57:04Z","timestamp":1760039824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074054722100413X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":39,"alternative-id":["S074054722100413X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108687","relation":{},"ISSN":["0740-5472"],"issn-type":[{"type":"print","value":"0740-5472"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the impact of social distancing measures implemented during COVID-19 pandemic on medications for opioid use disorder in West Virginia","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108687","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108687"}}